Juxtafoveal Telangiectasia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-05-30
Clinical Trial Update: Effect of Avastin in Juxtafoveal Telangiectasias [Phase 3]
This Phase 3 trial of bevacizumab (Avastin) for juxtafoveal telangiectasia has been withdrawn.